ELF2P3

Across TCGA pan-cancer cohorts, ELF2P3 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated ELF2P3 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher ELF2P3 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated ELF2P3 expression acts as an unfavorable survival marker, although some lineages such as UVM show a favorable association.

ACC, MESO, and UVM are the cancer types where ELF2P3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Tertile	All	0.212	0.833	<.001	126	view →
MESO	OS	Tertile	All	0.189	0.568	<.001	108	view →
UVM	OS	Median	All	0.843	0.443	<.001	69	view →
READ	OS	Tertile	All	0.165	0.674	<.001	27	view →
KIRC	DFS	Tertile	III,IV	0.572	0.772	.020	24	view →
BLCA	DFS	Tertile	All	0.170	0.602	.004	18	view →
LIHC	OS	Tertile	III,IV	0.117	0.535	.020	9	view →
UCEC	OS	Tertile	All	0.873	0.929	.027	6	view →
SKCM	OS	Quartile	IV	0.475	0.741	.010	3	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

ELF2P3–ACC (OS)

Open the ACC breakdown →